Compare BOOM & CNXU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BOOM | CNXU |
|---|---|---|
| Founded | 1965 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 109.5M | 92.8M |
| IPO Year | 1995 | 2025 |
| Metric | BOOM | CNXU |
|---|---|---|
| Price | $5.52 | $3.10 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 106.7K | ★ 329.9K |
| Earning Date | 10-27-2026 | 02-03-2027 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 89.02 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $609,840,000.00 | N/A |
| Revenue This Year | $0.34 | N/A |
| Revenue Next Year | $6.80 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.69 | $2.95 |
| 52 Week High | $9.20 | $13.66 |
| Indicator | BOOM | CNXU |
|---|---|---|
| Relative Strength Index (RSI) | 43.80 | 39.85 |
| Support Level | $5.50 | $3.05 |
| Resistance Level | $5.73 | $4.36 |
| Average True Range (ATR) | 0.26 | 0.56 |
| MACD | 0.02 | 0.08 |
| Stochastic Oscillator | 42.21 | 12.06 |
DMC Global Inc operates a diversified family of technical product and process businesses serving the energy, industrial and infrastructure markets. Its business is organized into three segments: Arcadia, DynaEnergetics, and NobelClad. Arcadia Products supplies architectural building products, including exterior and interior framing systems, windows, urtain walls, storefronts etc to the commercial construction market. NobelClad is involved in the production of explosion-welded clad metal plates for use in the construction of corrosion-resistant industrial processing equipment and specialized transition joints. DynaEnergetics driver, designs manufactures and distributes products utilized by the oil and gas industry principally for the perforation of oil and gas wells.
Conexeu Sciences Inc is an early-stage medical technology company. The company develops and supplies collagen-based technologies that helps doctors and patients regenerate tissue naturally, safely, and effectively. The company is focused on developing regenerative biomaterials that address relative needs in wound care, dentistry, and aesthetics. The company seek to provide physicians with device-based solutions that improve healing, restore soft tissue, and enhance patient outcomes across multiple clinical settings. The company focuses durable, and growing addressable markets in regenerative aesthetics, wound care, 3D-printed tissue structures, veterinary wound repair, and dental soft-tissue regeneration.